top of page
Biotech Stories, News & Events

Finnish Bioindustries FIB appoints Alexandra Peth as Managing Director

  • Apr 19, 2023
  • 1 min read

Finnish Bioindustries long-term director Carmela Kantor-Aaltonen is retiring in August 2023. M.Sc. Alexandra Peth has been appointed as her successor, in a  Managing Director role for Finnish Bioindustries starting on August 1st, 2023.



Finnish Bioindustries FIB appoints Alexandra Peth as Managing Director


Alexandra currently works as Senior Advisor of innovation and finance at Chemical Industry Federation of Finland. She will continue working for Chemical Industry Federation of Finland beside her role as Managing Director of Finnish Bioindustries.



“Finnish Bioindustries FIB is a trusted partner among stakeholders, and I am very proud for the opportunity to represent our member companies and make our voice even clearer in the social and political debate. Bioindustry has a promising future ahead as biotechnology will be an important enabler for new innovations, products and services for green transition and health sector,” says Alexandra Peth.

“Alexandra’s knowledge of sustainability and green transition will bring new possibilities to Finnish Bioindustries that will strengthen the voice of biotech industry and drive the industry’s development and visibility further,” says Maarit Merla, Chair of the Finnish Bioindustries Board.

“We also want to thank warmly our long-term director Carmela Kantor-Aaltonen for her devoted services for Finnish Bioindustries,” says Merla.

Finnish Bioindustries FIB is Finland's biotechnology industry association, established in 1997. It is a private, independent non-profit organisation.

Microscopic view of blue-grey yeast cells

Similar Stories from FIB

Member Profile: TILT Biotherapeutics – Developer of a Virus-Based Cancer Therapy

21/01/26

Member Profile: TILT Biotherapeutics – Developer of a Virus-Based Cancer Therapy

Finns Fighting Cancer – A Small Nation with Global Impact

18/12/25

Finns Fighting Cancer – A Small Nation with Global Impact

Member Spotlight: Herantis Pharma – aiming to stop the progression of Parkinson’s disease

10/11/25

Member Spotlight: Herantis Pharma – aiming to stop the progression of Parkinson’s disease

HAMK invests in biotechnology

29/10/25

HAMK invests in biotechnology

bottom of page